- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-15
DOI
10.3389/fimmu.2021.592031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
- (2021) Zhuting Hu et al. NATURE MEDICINE
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- pVACtools: a computational toolkit to identify and visualize cancer neoantigens
- (2020) Jasreet Hundal et al. Cancer Immunology Research
- TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer
- (2020) Timothy John Looney et al. Frontiers in Immunology
- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy
- (2020) Jing Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening
- (2020) Huang Huang et al. NATURE BIOTECHNOLOGY
- Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases
- (2020) Zheng Hu et al. NATURE GENETICS
- MR1-Restricted T Cells Are Unprecedented Cancer Fighters
- (2020) Alessandro Vacchini et al. Frontiers in Immunology
- Cancer immunotherapy with γδ T cells: many paths ahead of us
- (2020) Dieter Kabelitz et al. Cellular & Molecular Immunology
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- Characteristics of TCR Repertoire Associated With Successful Immune Checkpoint Therapy Responses
- (2020) Joel Kidman et al. Frontiers in Immunology
- Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer
- (2020) Sri Krishna et al. SCIENCE
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Biophysicochemical motifs in T cell receptor sequences distinguish repertoires from tumor-infiltrating lymphocytes and adjacent healthy tissue
- (2019) Jared Ostmeyer et al. CANCER RESEARCH
- Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence
- (2019) Katey S. S. Enfield et al. Journal for ImmunoTherapy of Cancer
- Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
- (2019) Kellie N. Smith et al. Journal for ImmunoTherapy of Cancer
- Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
- (2019) Gal Cafri et al. Nature Communications
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- microRNA-142–mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance
- (2019) Nelomi Anandagoda et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer
- (2019) Seon Hee Chang ARCHIVES OF PHARMACAL RESEARCH
- A randomized Phase 2b study of GVAX pancreas and CRS-207 compared to chemotherapy in previously-treated metastatic pancreatic adenocarcinoma patients (ECLIPSE Study)
- (2019) Dung T. Le et al. CLINICAL CANCER RESEARCH
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.
- (2019) Giles W. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- Induction of neoantigen-reactive T cells from healthy donors
- (2019) Muhammad Ali et al. Nature Protocols
- Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy
- (2019) Christian M. Schürch et al. THYROID
- The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
- (2019) Yaxiong Zhang et al. Journal for ImmunoTherapy of Cancer
- Clonal replacement of tumor-specific T cells following PD-1 blockade
- (2019) Kathryn E. Yost et al. NATURE MEDICINE
- High-throughput targeted long-read single cell sequencing reveals the clonal and transcriptional landscape of lymphocytes
- (2019) Mandeep Singh et al. Nature Communications
- Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer
- (2019) Jie Zhou et al. Biomed Research International
- Functional Enrichment and Analysis of Antigen-Specific Memory B Cell Antibody Repertoires in PBMCs
- (2019) Eric Waltari et al. Frontiers in Immunology
- Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
- (2019) Stefan Audehm et al. Frontiers in Immunology
- Clonality of CD4+ Blood T Cells Predicts Longer Survival With CTLA4 or PD-1 Checkpoint Inhibition in Advanced Melanoma
- (2019) Akiko Arakawa et al. Frontiers in Immunology
- Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
- (2019) Beatris Mastelic-Gavillet et al. Frontiers in Immunology
- Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer
- (2019) Song Liu et al. Journal for ImmunoTherapy of Cancer
- High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules
- (2019) Andreas Moritz et al. Science Immunology
- Empty peptide-receptive MHC class I molecules for efficient detection of antigen-specific T cells
- (2019) Sunil Kumar Saini et al. Science Immunology
- Tissue-Resident Memory T Cells in Cancer Immunosurveillance
- (2019) Simone L. Park et al. TRENDS IN IMMUNOLOGY
- Best practices for bioinformatic characterization of neoantigens for clinical utility
- (2019) Megan M. Richters et al. Genome Medicine
- Tumor Neoantigens: When Too Much of a Good Thing Is Bad
- (2019) Anne Trinh et al. CANCER CELL
- Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
- (2019) Amaury Leruste et al. CANCER CELL
- Circulating Tumor Cells: Diagnostic and Therapeutic Applications
- (2018) Eric Lin et al. Annual Review of Biomedical Engineering
- Personalized neoantigen vaccines: A new approach to cancer immunotherapy
- (2018) Amanda R. Aldous et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
- (2018) Matthew D. Hellmann et al. CANCER CELL
- Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment
- (2018) Hirotake Tsukamoto et al. CANCER RESEARCH
- Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
- (2018) Marvin H. Gee et al. CELL
- Induction of Neoantigen-specific Cytotoxic T Cells and Construction of T-cell Receptor-engineered T cells for Ovarian Cancer
- (2018) Tatsuo Matsuda et al. CLINICAL CANCER RESEARCH
- CD103+Tumor-Resident CD8+T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
- (2018) Jarem Edwards et al. CLINICAL CANCER RESEARCH
- Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer
- (2018) Claire Vennin et al. GASTROENTEROLOGY
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy
- (2018) Lukasz Bialkowski et al. INTERNATIONAL JOURNAL OF CANCER
- Redirection to the bone marrow improves T cell persistence and antitumor functions
- (2018) Anjum B. Khan et al. JOURNAL OF CLINICAL INVESTIGATION
- Early B cell changes predict autoimmunity following combination immune checkpoint blockade
- (2018) Rituparna Das et al. JOURNAL OF CLINICAL INVESTIGATION
- The perfect personalized cancer therapy: cancer vaccines against neoantigens
- (2018) Luigi Aurisicchio et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
- (2018) Xinyi Guo et al. NATURE MEDICINE
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Strelka2: fast and accurate calling of germline and somatic variants
- (2018) Sangtae Kim et al. NATURE METHODS
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
- (2018) Janos L. Tanyi et al. Science Translational Medicine
- Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
- (2018) Chung-Han Lee et al. TRENDS IN IMMUNOLOGY
- The inducers of immunogenic cell death for tumor immunotherapy
- (2018) Xiuying Li TUMORI
- Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
- (2018) Emelie Berglund et al. Nature Communications
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses
- (2018) Qingda Meng et al. Oncotarget
- Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma
- (2018) Davide Valentini et al. Oncotarget
- Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway
- (2018) Yan Zhao et al. Oncotarget
- Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer
- (2018) Noomi Vainer et al. Oncotarget
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
- (2018) Brianne Cruickshank et al. Frontiers in Immunology
- Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
- (2018) Aurélie Durgeau et al. Frontiers in Immunology
- A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept
- (2018) Daniel Satgé Frontiers in Immunology
- Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
- (2018) Benjamin J. Wolf et al. Frontiers in Immunology
- Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
- (2018) Yugang Guo et al. Frontiers in Immunology
- Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme
- (2018) Liu Zhenjiang et al. EBioMedicine
- Targeting Macrophages in Cancer: From Bench to Bedside
- (2018) Ashleigh R. Poh et al. Frontiers in Oncology
- The inducers of immunogenic cell death for tumor immunotherapy
- (2018) Xiuying Li TUMORI JOURNAL
- MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
- (2018) Weijing Cai et al. BMC GENOMICS
- Interleukin-17-producing γδ T (γδ 17) cells in inflammatory diseases
- (2018) Aoi Akitsu et al. IMMUNOLOGY
- Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results.
- (2018) Vamsidhar Velcheti et al. JOURNAL OF CLINICAL ONCOLOGY
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- Principles of adoptive T cell therapy in cancer
- (2018) Özcan Met et al. Seminars in Immunopathology
- Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma
- (2018) Shelly Kalaora et al. Cancer Discovery
- Pan-cancer analysis of neoepitopes
- (2018) Gabriel N. Teku et al. Scientific Reports
- T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
- (2018) Jonathan A. Trujillo et al. Cancer Immunology Research
- Trial watch: peptide-based vaccines in anticancer therapy
- (2018) Lucillia Bezu et al. OncoImmunology
- Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16–Related Cancer
- (2018) Erminia Massarelli et al. JAMA Oncology
- KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer
- (2018) Qingda Meng et al. Frontiers in Oncology
- Neoepitope targets of tumour-infiltrating lymphocytes from patients with pancreatic cancer
- (2018) Qingda Meng et al. BRITISH JOURNAL OF CANCER
- Evolution of Metastases in Space and Time under Immune Selection
- (2018) Mihaela Angelova et al. CELL
- B Cell–Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses
- (2018) Melissa M. Walker et al. JOURNAL OF IMMUNOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury
- (2018) Oliver J. Harrison et al. SCIENCE
- Noncoding regions are the main source of targetable tumor-specific antigens
- (2018) Céline M. Laumont et al. Science Translational Medicine
- CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
- (2018) Qingda Meng et al. Scientific Reports
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer
- (2018) Monica M. Olcina et al. Cell Reports
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
- (2018) Claudia Rossig et al. Frontiers in Oncology
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
- (2017) Jennifer G. Abelin et al. IMMUNITY
- CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human Skin
- (2017) Stanley Cheuk et al. IMMUNITY
- Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy
- (2017) Cristina Maccalli et al. IMMUNOLOGICAL INVESTIGATIONS
- Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
- (2017) Yong-Chen Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Results from a phase 2b, randomized, multicenter study of GVAX pancreas and CRS-207 compared to chemotherapy in adults with previously-treated metastatic pancreatic adenocarcinoma (ECLIPSE Study).
- (2017) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer
- (2017) Yoshitaro Shindo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MA15.10 Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
- (2017) Zhong-Yi Dong et al. Journal of Thoracic Oncology
- An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer
- (2017) Takahiro Karasaki et al. Journal of Thoracic Oncology
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Quantifiable predictive features define epitope-specific T cell receptor repertoires
- (2017) Pradyot Dash et al. NATURE
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- Chromatin states define tumour-specific T cell dysfunction and reprogramming
- (2017) Mary Philip et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- The problem with neoantigen prediction
- (2017) NATURE BIOTECHNOLOGY
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling
- (2017) In Ah Park et al. PLoS One
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational landscape of RNA-binding proteins in human cancers
- (2017) Yaseswini Neelamraju et al. RNA Biology
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- STING-mediated DNA sensing in cancer immunotherapy
- (2017) Xiang Zhou et al. Science China-Life Sciences
- The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy
- (2017) Yuanbing Wu et al. Translational Research
- Prognostic value of MICA/B in cancers: a systematic review and meta-analysis
- (2017) Yijing Zhao et al. Oncotarget
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
- (2017) Eva Bräunlein et al. Frontiers in Immunology
- ‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization
- (2017) Markus Müller et al. Frontiers in Immunology
- HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
- (2017) Barbara Seliger et al. OncoImmunology
- CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
- (2017) Fenne L. Komdeur et al. OncoImmunology
- Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis
- (2017) Liu Zhenjiang et al. EBioMedicine
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- IL-17A-producing CD30+Vδ1 T cells drive inflammation-induced cancer progression
- (2016) Yoshitaka Kimura et al. CANCER SCIENCE
- γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
- (2016) Donnele Daley et al. CELL
- Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
- (2016) Thomas R. Flint et al. Cell Metabolism
- Human γδT-cell subsets and their involvement in tumor immunity
- (2016) Dang Wu et al. Cellular & Molecular Immunology
- The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator
- (2016) Xiao-Guang Wang et al. CHINESE MEDICAL JOURNAL
- CD103 and Intratumoral Immune Response in Breast Cancer
- (2016) Z.-Q. Wang et al. CLINICAL CANCER RESEARCH
- Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
- (2016) David Balli et al. CLINICAL CANCER RESEARCH
- CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma
- (2016) Hagma H. Workel et al. EUROPEAN JOURNAL OF CANCER
- Carbohydrates as T-cell antigens with implications in health and disease
- (2016) Lina Sun et al. GLYCOBIOLOGY
- Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
- (2016) Kanika Garg et al. HUMAN PATHOLOGY
- Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
- (2016) Hans-Christian Bösmüller et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The host STING pathway at the interface of cancer and immunity
- (2016) Leticia Corrales et al. JOURNAL OF CLINICAL INVESTIGATION
- Pan-Specific Prediction of Peptide–MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity
- (2016) Michael Rasmussen et al. JOURNAL OF IMMUNOLOGY
- Landscape of tumor-infiltrating T cell repertoire of human cancers
- (2016) Bo Li et al. NATURE GENETICS
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
- (2016) E. Stronen et al. SCIENCE
- Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
- (2016) Marij J. Welters et al. Science Translational Medicine
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
- (2016) Douglas B. Johnson et al. Nature Communications
- PD-1 Shapes B Cells as Evildoers in the Tumor Microenvironment
- (2016) Z. Ren et al. Cancer Discovery
- PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
- (2016) X. Xiao et al. Cancer Discovery
- Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
- (2016) Diana Rose E. Ranoa et al. Oncotarget
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Mutation Drivers of Immunological Responses to Cancer
- (2016) E. Porta-Pardo et al. Cancer Immunology Research
- Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
- (2016) A. Pasetto et al. Cancer Immunology Research
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
- (2016) Bodo E. Lippitz et al. OncoImmunology
- Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability
- (2016) Emilia Bigaeva et al. PLoS One
- The role of CD95 and CD95 ligand in cancer
- (2015) M E Peter et al. CELL DEATH AND DIFFERENTIATION
- New Cell Sources for T Cell Engineering and Adoptive Immunotherapy
- (2015) Maria Themeli et al. Cell Stem Cell
- The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
- (2015) Mateusz Legut et al. Cellular & Molecular Immunology
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
- (2015) M. Cioffi et al. CLINICAL CANCER RESEARCH
- Spatial dynamics of TRAIL death receptors in cancer cells
- (2015) Julianne D. Twomey et al. DRUG RESISTANCE UPDATES
- Antibody-based immunotherapy of solid cancers: progress and possibilities
- (2015) Christopher F Nicodemus Immunotherapy
- Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
- (2015) Cyrille J. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
- (2015) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder
- (2015) Bo Wang et al. JOURNAL OF UROLOGY
- Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
- (2015) Aifen Lin et al. MOLECULAR MEDICINE
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Commensal–dendritic-cell interaction specifies a unique protective skin immune signature
- (2015) Shruti Naik et al. NATURE
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
- (2015) Shu-Feng Zhou et al. Drug Design Development and Therapy
- Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
- (2015) Rikke Andersen et al. Human Vaccines & Immunotherapeutics
- Human Tumor Antigens and Cancer Immunotherapy
- (2015) Nathalie Vigneron Biomed Research International
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients
- (2015) Carlo Fremd et al. OncoImmunology
- Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers
- (2015) Mini Bharathan et al. Journal for ImmunoTherapy of Cancer
- microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements
- (2015) Alexander Schwickert et al. PLoS One
- HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
- (2015) Giuseppe Sconocchia et al. NEOPLASIA
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer
- (2014) Eva-Maria Surmann et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation
- (2014) Tomonori Kato et al. CELLULAR IMMUNOLOGY
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
- (2014) Y.-C. Lu et al. CLINICAL CANCER RESEARCH
- Interleukin-6: a villain in the drama of pancreatic cancer development and progression
- (2014) Reinhild Holmer et al. Hepatobiliary & Pancreatic Diseases International
- NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
- (2014) Ji-Li Chen et al. INTERNATIONAL JOURNAL OF CANCER
- CD1d expression in renal cell carcinoma is associated with higher relapse rates, poorer cancer-specific and overall survival
- (2014) Tsung Wen Chong et al. JOURNAL OF CLINICAL PATHOLOGY
- Role and Regulation of CD1d in Normal and Pathological B Cells
- (2014) Mohammed S. Chaudhry et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell Function
- (2014) W. Hou et al. JOURNAL OF VIROLOGY
- Going back to class I: MHC and immunotherapies for childhood cancer
- (2014) Kellie B. Haworth et al. PEDIATRIC BLOOD & CANCER
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Resident memory CD8 T cells trigger protective innate and adaptive immune responses
- (2014) J. M. Schenkel et al. SCIENCE
- Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
- (2013) E. P. Hui et al. CANCER RESEARCH
- Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
- (2013) Y. Zhang et al. CANCER RESEARCH
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
- (2013) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Gammadelta T Cells: Innately Adaptive Immune Cells?
- (2013) Leonardo M. R. Ferreira INTERNATIONAL REVIEWS OF IMMUNOLOGY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- Insights into the role of the beta-2 microglobulin D-strand in amyloid propensity revealed by mass spectrometry
- (2013) Aneika C. Leney et al. Molecular BioSystems
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin
- (2013) Laura K Mackay et al. NATURE IMMUNOLOGY
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1
- (2012) Pei-Ming Yang et al. Epigenetics
- Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity
- (2012) Mikkel Harndahl et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- Hereditary Systemic Amyloidosis Due to Asp76Asn Variant β2-Microglobulin
- (2012) Sophie Valleix et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: Unusually high frequency of down-regulation in breast cancer tissues
- (2012) Toshihiko Torigoe et al. PATHOLOGY INTERNATIONAL
- Differentiation of human peripheral blood V 1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells
- (2011) D. V. Correia et al. BLOOD
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
- (2011) Hirohito Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
- (2011) D. T. Le et al. CLINICAL CANCER RESEARCH
- Adoptive Immunotherapy for Advanced Non-small CellLung Cancer Using Zoledronate-expanded γδTCells
- (2011) Miki Sakamoto et al. JOURNAL OF IMMUNOTHERAPY
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
- (2011) Gooitzen M van Dam et al. NATURE MEDICINE
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
- (2011) M. Gooden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- Human Leukocyte Antigens A*3001 and A*3002 Show Distinct Peptide-Binding Patterns of theMycobacterium tuberculosisProtein TB10.4: Consequences for Immune Recognition
- (2010) Rebecca Axelsson-Robertson et al. Clinical and Vaccine Immunology
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
- (2010) Jun Nakajima et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (αE/β7 Integrin) in high-grade serous ovarian cancer
- (2010) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- Identification of an alternate splice form of tapasin in human melanoma
- (2010) Alan Belicha-Villanueva et al. HUMAN IMMUNOLOGY
- A Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer
- (2010) Rodryg Ramlau et al. Journal of Thoracic Oncology
- Design of Agonistic Altered Peptides for the Robust Induction of CTL Directed towards H-2Db in Complex with the Melanoma-Associated Epitope gp100
- (2009) M. J.B. van Stipdonk et al. CANCER RESEARCH
- DCVax®-Brain and DC vaccines in the treatment of GBM
- (2009) Christopher J Wheeler et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8+ T-cell responses
- (2009) Rebecca Axelsson-Robertson et al. IMMUNOLOGY
- Tumor-reactive CD8+T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide® ISA-51: Association with survival
- (2009) Julia Karbach et al. INTERNATIONAL JOURNAL OF CANCER
- Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes
- (2009) Sara Michel et al. INTERNATIONAL JOURNAL OF CANCER
- Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele
- (2009) E. Spierings et al. JOURNAL OF IMMUNOLOGY
- Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus
- (2009) Thomas Gebhardt et al. NATURE IMMUNOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition
- (2009) S. Nicholls et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now